-
Celebrating 10 Years of Sekisui XenoTech
Sep 18, 2018, 10:39 AM by Michael CroftKANSAS CITY, KS, UNITED STATES - Sep 18, 2018 - 10 years ago Sekisui Chemical Company acquired XenoTech and the future of the groundbreaking, innovative CRO was assuredFull story -
Seqster’s Perfect Timing, Powerful Platform Might Change Health
Sep 18, 2018, 10:25 AM by Michael CroftFull storyBio-IT World | Early adopters of Google Health or Microsoft Health Vault may remember the process of consolidating personal health records with a good deal of frustration or just a sense of futility. But Seqster, a privately-held health data management platform that emerged from stealth mode this past February, believes they have gotten it right this time.
-
Creative Biolabs Illustrated Its Newly-developed Antibody Affinity Maturation Service
Sep 18, 2018, 01:38 AM by Michael CroftSHIRLEY, NY - Sep 18, 2018 - Sep 18th, 2018, Creative Biolabs, as one of the most experienced supplier in various antibody production and engineering fields, has recently released its newly-developed affinity maturation antibody, which is an indispensable process to improve antibody affinity for an antigenFull story -
LifeArc® announces new CEO appointment
Sep 17, 2018, 08:16 AM by Michael CroftLONDON - Sep 17, 2018 - London, UK, September 4th, 2018. LifeArc, one of the UK's leading medical research charities, is delighted to announce the appointment of Melanie Lee, PhD, CBE as its new Chief Executive Officer (CEO), effective 1st November 2018Full story -
Identification of synthetic, macrocyclic, orally bioavailable cyclophilin inhibitors with potent HCV activity, published in The Journal of Medicinal Chemistry
Sep 17, 2018, 05:09 AM by Michael CroftCAMBRIDGE AND ONGAR, UK - Sep 17, 2018 - A paper entitled Discovery of a Potent and Orally Bioavailable Cyclophilin Inhibitor Derived from the Sanglifehrin Macrocycle by authors from Selcia, Cypralis and Gilead has been selected as a featured article by the editors of The Journal of Medicinal ChemistryFull story -
Creative Diagnostics Launches Recombinant HPV L1 VLP for Science Research
Sep 17, 2018, 04:54 AM by Michael CroftSHIRLEY, NY, UNITED STATES - Sep 17, 2018 - As a leader in the manufacture of raw materials, reagents and antibodies for biotechnology industry, Creative Diagnostics now establishes a global-leading virus-like particles (VLPs) manufacture platform using ExFull story -
Large-Scale Global Genome Projects Choose PacBio Sequencing To Help Decode Life
Sep 14, 2018, 08:20 AM by Michael CroftFull storyBio-IT World News Brief | The Vertebrate Genomes Project recently released the first 15 of an anticipated 66,000 high-quality reference genomes that will eventually include all vertebrate species on Earth.
-
Particle Sciences appoints new president
Sep 13, 2018, 11:59 AM by Michael CroftMANCHESTER, UNITED KINGDOM - Sep 13, 2018 - BETHLEHEM, PA, September 13th, 2018 - Particle Sciences, a Lubrizol LifeSciences company and leading pharmaceutical contract development and manufacturing organization (CDMO), announces the appointment of DrFull story -
Recipharm connects to European Hub for serialisation compliance
Sep 13, 2018, 11:09 AM by Michael CroftSTOCKHOLM, SWEDEN - Sep 13, 2018 - Recipharm, a leading contract development and manufacturing organisation (CDMO) has successfully received European Medicines Verification Organisation (EMVO) approval to submit serialisation data to the European HubFull story -
Certara Acquires Pirana™, a Leading Pharmacometrics Modeling Workbench
Sep 13, 2018, 09:03 AM by Michael CroftPRINCETON, NJ, US - Sep 13, 2018 - Certara®, the global leader in model-informed drug development, regulatory science, market access and real-world evidence solutions, announced today that it has acquired Pirana, a widely used product for connecting and organizing pharmacometric modeling results as well as providing interfaces to a range of software tools used in pharmacometrics modelingFull story -
Google Unveils Dataset Search For Scientists, Other Data Junkies
Sep 12, 2018, 10:09 AM by Michael CroftTOP500 | Google has added a Dataset Search app to its empire of web-based tools, making it easier for researchers, analysts, and anyone else with an affection for data to access publicly available repositories.Full story -
Sekisui XenoTech Adds Rodent, Monkey Hepatocytes to Patented CryostaX® Product Line
Sep 12, 2018, 09:50 AM by Michael CroftKANSAS CITY, KS, UNITED STATES - Sep 12, 2018 - Sekisui XenoTech is expanding its catalog of CryostaX® in vitro drug discovery and preclinical drug development test systems to include pooled Sprague-Dawley rat hepatocytes, which became available in July, CD-1 mouse hepatocytes, which were released this week, and Cynomolgus monkey hepatocytes, which are expected in OctoberFull story -
MR Solutions’ Founder shortlisted for the 2018 NatWest Great British Entrepreneur Awards
Sep 12, 2018, 05:35 AM by Michael CroftGUILDFORD, UNITED KINGDOM - Sep 12, 2018 - Founder and Chairman, Dr David Taylor, of Guildford based MR Solutions has been shortlisted as an Innovation Entrepreneur of the Year for London and the South East in the 2018 NatWest Great British Entrepreneur AwardsFull story -
Rho Ranks First for Extra-Large Company by Triangle Business Journal Best Places to Work
Sep 11, 2018, 14:10 PM by Michael CroftCHAPEL HILL, NC - Sep 11, 2018 - For Immediate releaseRho Ranks First for Extra-Large Company byTriangle Business Journal Best Places to WorkCRO recognized for its company culture and flexible work environmentChapel Hill, NC - September 11, 2018 - Rho, a full-service contract research organization (CRO) focused on bringing new products to market through a full range of product development services, announced today that the Triangle Business Journal has ranked the company as the number one extra-large companyFull story -
Biodesy Announces New CEO and $20 Million Series C Financing to Accelerate Expansion into Biotherapeutics Discovery and Development Market
Sep 11, 2018, 10:00 AM by Michael CroftSOUTH SAN FRANCISCO, CA, USA - Sep 10, 2018 - Biodesy Inc., a next-generation biomolecule characterization company, today announced the promotion of Ariel GFull story -
Pivotal CRISPR Patent Battle Won By Broad Institute
Sep 10, 2018, 18:10 PM by Michael CroftNature | On 10 September, the US Court of Appeals for the Federal Circuit awarded the pivotal intellectual property to the Broad Institute of Cambridge, Massachusetts, upholding a previous decision by the US Patent and Trademark Office. The decision spells defeat for a team of inventors that includes molecular biologist Jennifer Doudna University of California, Berkeley (UC).Full story -
H1 To Incorporate Key Opinion Leader Data In Veeva CRM Platform
Sep 10, 2018, 15:12 PM by Michael CroftNEW YORK CITY, NY, UNITED STATES - Sep 10, 2018 - H1 To Incorporate Key Opinion LeaderData In Veeva CRM Platform H1 combined with Veeva CRM will help life sciences clients findFull story
the right influencers in minutes instead of months New York, NY - September 10, 2018 - H1, the first company to arm healthcare organizations with live data insights to help fight diseases, today announced that it has integrated H1's Key Opinion Leader (KOL) data solution, H1 Curie, in Veeva CRM -
Christian Marcazzo joins IDBS as Vice President and General Manager
Sep 10, 2018, 12:49 PM by Michael CroftGUILDFORD, UK - Sep 10, 2018 - Christian will be responsible for running IDBS and growing the Informatics Solutions business of the Danaher Life Sciences PlatformFull story -
XtenCHO™, the new transient expression system breaking records
Sep 10, 2018, 10:42 AM by Michael CroftSTRASBOURG, FRANCE - Sep 10, 2018 - ProteoGenix managed to develop XtenCHO™, a transient expression system outperforming the productivity of the best and most popular cell lines on the marketxFull story -
Next-Generation Knowledgebases Are Required For Interpreting Data In Precision Oncology
Sep 10, 2018, 10:25 AM by Michael CroftFull storyBio-IT World | While precision medicine has undeniably had an enormous impact on oncology and the understanding and treatment of cancer patients has improved, data interpretation still remains a significant bottleneck. To address this, The Jackson Laboratory built a Clinical Knowledgebase to provide evidence-based information to clinicians, researchers, and ultimately patients.